|
NTLA
|
Intellia Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ITGR
|
Integer Holdings Corporation
|
0.04%
|
US
|
NYSE
|
|
ISEE
|
IVERIC bio, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
IRTC
|
iRhythm Technologies, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
GKOS
|
Glaukos Corporation
|
0.04%
|
US
|
NYSE
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
AXNX
|
Axonics Modulation Technologies, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.04%
|
US
|
NASDAQ
|
|
OSH
|
Oak Street Health, Inc.
|
0.04%
|
US
|
NYSE
|
|
EVH
|
Evolent Health, Inc
|
0.04%
|
US
|
NYSE
|
|
GH
|
Guardant Health, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.03%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
TLRY
|
Tilray, Inc.
|
0.03%
|
US
|
NASDAQ
|